These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32690502)

  • 1. Quality of advertisements for prescription drugs in family practice medical journals published in Australia, Canada and the USA with different regulatory controls: a cross-sectional study.
    Diep D; Mosleh-Shirazi A; Lexchin J
    BMJ Open; 2020 Jul; 10(7):e034993. PubMed ID: 32690502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of drug advertisements in medical journals under new law regulating the marketing of pharmaceutical products in Switzerland.
    Santiago MG; Bucher HC; Nordmann AJ
    BMC Med Inform Decis Mak; 2008 Dec; 8():61. PubMed ID: 19117521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of pharmaceutical advertisements in medical journals: a systematic review.
    Othman N; Vitry A; Roughead EE
    PLoS One; 2009 Jul; 4(7):e6350. PubMed ID: 19623259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States.
    Othman N; Vitry AI; Roughead EE
    BMC Public Health; 2010 May; 10():294. PubMed ID: 20509953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug advertisements in two dermatology journals: a critical comparison of IJDVL and JAAD.
    Gahalaut P; Chauhan S; Mishra N; Rastogi M; Thakur R
    Indian J Dermatol Venereol Leprol; 2014; 80(2):115-21. PubMed ID: 24685846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study.
    Montgomery BD; Mansfield PR; Spurling GK; Ward AM
    BMC Public Health; 2008 May; 8():167. PubMed ID: 18492241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence of pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribing.
    Korenstein D; Keyhani S; Mendelson A; Ross JS
    PLoS One; 2011; 6(8):e23336. PubMed ID: 21858076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic assessment of opioid advertisements in general medical journals.
    Kirubarajan A; Got T; Persaud N; O'Neill B
    Can Fam Physician; 2023 Mar; 69(3):192-197. PubMed ID: 36944508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug company advertising in medical journals about the health-economic advantages of their products for 2000-2006 versus 1990-1999.
    Palmer JA; Timm AR; Neumann PJ
    J Manag Care Pharm; 2008 Oct; 14(8):749-55. PubMed ID: 18983204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of claims and references found in Australian pharmacy journal advertisements.
    Mandoh M; Curtain CM
    Int J Pharm Pract; 2017 Oct; 25(5):365-370. PubMed ID: 27896882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicines information in medical journal advertising in Australia, Malaysia and the United States: A comparative cross-sectional study.
    Othman N; Vitry AI; Roughead EE
    South Med Rev; 2010 Feb; 3(1):11-8. PubMed ID: 23093878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical advertisements in leading medical journals: experts' assessments.
    Wilkes MS; Doblin BH; Shapiro MF
    Ann Intern Med; 1992 Jun; 116(11):912-9. PubMed ID: 1580449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal.
    Lexchin J; Holbrook A
    CMAJ; 1994 Jul; 151(1):47-54. PubMed ID: 8004560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic content in medical journal advertisements for medical devices and prescription drugs.
    Ackerly DC; Glickman SW; Schulman KA
    Pharmacoeconomics; 2010; 28(5):429-38. PubMed ID: 20402543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Industry guidelines, laws and regulations ignored: quality of drug advertising in medical journals.
    Lankinen KS; Levola T; Marttinen K; Puumalainen I; Helin-Salmivaara A
    Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):789-95. PubMed ID: 15486957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the volume of pharmaceutical advertisements between print general medical journals.
    Gettings J; O'Neill B; Chokshi DA; Colbert JA; Gill P; Lebovic G; Lexchin J; Persaud N
    PLoS One; 2014; 9(1):e84790. PubMed ID: 24416286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complaints addressed by regulatory authorities in drug advertising targeted at consumers: Cases across three, different countries.
    Song SY; Lee JH; Kim SC; Choi JW; Bae J; Kim E
    Res Social Adm Pharm; 2019 Oct; 15(10):1274-1279. PubMed ID: 30552049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription drug advertising: medical journal practices under different types of control.
    Najman JM; Siskind V; Bain C
    Med J Aust; 1979 May; 1(10):420-4. PubMed ID: 470667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical advertisement claims in Australian medical publications.
    Loke TW; Koh FC; Ward JE
    Med J Aust; 2002 Sep; 177(6):291-3. PubMed ID: 12225274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical advertisements in prescribing software: an analysis.
    Harvey KJ; Vitry AI; Roughead E; Aroni R; Ballenden N; Faggotter R
    Med J Aust; 2005 Jul; 183(2):75-9. PubMed ID: 16022612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.